All lobbying filings

AKIN GUMP STRAUSS HAUER & FELD

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Trade association.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $120,000.00 income · posted Apr 20, 2026

Official filing document

Bills named in this filing 2

HR 3160
PREVAIL Act
S 1553
PREVAIL Act

Lobbying activity 3

Health Issues

Issues related to drug pricing proposals; Issues related to Rx oversight; Issues related to PBM oversight; Issues related to budget reconciliation; Issues related to Most Favored Nation proposals.

Trade (domestic/foreign)

Issues related to IP protection; Issues related to market access; Issues related to PhRMA Section 232 tariffs.

Issues related to patent reform legislation; Issues related to H.R. 3160/S. 1553 - PREVAIL Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.